|
The Seasonal Flu vaccine delivery is being delayed by the production of the H1N1 vaccine. Please email our office at the address below and request to be put on our Blast List so you are first to receive important updates from our office!
H1N1Update:
We have received a supply of H1N1 Flu vaccine. Please call our front desk to schedule your appointment. Please be patient with us as the amount of the vaccine allocated to us as well as the frequency of shipment cannot be controlled by our practice.
01/19/2010 Update: Our next Flu Clinic will be January 30th. Please call now to reserve your spot.
For more information you may check these websites: www.cdc.gov/H1N1flu/ and www.texasflu.org
To receive the H1N1 Flu Mist vaccine, your child can not have a history of diabetes, heart disease or asthma. If your child is under 5 years of age, they should have no episodes of wheezing for the last 12 months to receive this vaccine.
Blast List
To be the first to receive important informational updates from our practice about flu vaccine, seasonal changes and other important messages please send an email to blastlist@aacpediatrics.com. When you email, please include the email you would like to receive updates on and if you would like to be added to our phone blast, please include the phone number you would like called or texted. We recently sent a blast out to over 600 phones with an update to H1N1 vaccine delivery.
This is a one-way messaging system that we will use to send you the latest news from All About Children Pediatrics. Your information will not be shared or mass marketed with any other vendor or promotions program. Please do not send any medical or appointment inquiries to this address.
Breaking News! HIB (Hemophilus) VACCINE UPDATE
As you may have read there has been a recall of 1 million doses of HIB vaccine, due to a problem with the processing of the vaccine. All of our HIB vaccine is from a different company than the one recalled. All the potentially contaminated vaccine has been recalled, and there have been no infections or other problems related to the recalled vaccine. The immunity for those babies vaccinated is not in question. If your child had any infection from the vaccine, it would have been a mild redness or infection at the injection site - - - not serious infection. And this would have occurred within a few days of the vaccination.
This does affect us, however only in that our supply of HIB vaccine will be limited during the next year, because there are only 2 manufacturers in the U.S. As per AAP and CDC guidelines, we will be suspending the 12-18 month HIB dose for all children until the national supply is back up. Your children should still have adequate coverage and immunity to HIB.
THE SAFEST SEAT: APPROPRIATE CHILD SAFETY SEAT PLACEMENT
Child safety seats installed in the rear seat of a motor vehicle protect children in motor vehicle crashes. Recent advances in child-restraint system (CRS) design and changing patterns of child safety seat use have prompted the need to reevaluate the evidence in support of these recommendations. In the study, "Seating Patterns and Corresponding Risk of Injury Among 0- to 3-Year-Old Children in Child Safety Seats," the most common seating position for children using a CRS is the rear passenger side. Use of this position increases as children get older. However, child occupants aged 0-3 years seated in the center rear had a 43 percent lower injury risk compared with children in either of the rear outboard positions. Study authors offer updated evidence for the current recommendations that the center rear is the safest seat position for children restrained in a CRS, but they do not indicate that a child seated in an outboard position is a poor choice. Rather, they suggest that installing a CRS in the center rear position further reduces the risk of injury and enhances the protection already offered by child safety seats installed in the outboard position.
[Monday, May 5, at 12:01 a.m. ET. For more information contact Dana Mortensen from The Children’s Hospital of Philadelphia at 267-426-6092 or mortensen@email.chop.edu ]
|